TY - STD TI - International Diabetes Federation. (2016) Diabetes Atlas, 7th ed. [Internet]. Available from https://doi.org/www.diabetesatlas.org. Accessed May 21, 2017. UR - http://www.diabetesatlas.org ID - ref1 ER - TY - JOUR AU - Braithwaite, D. AU - Boffetta, P. AU - Rebbeck, T. R. AU - Meyskens, F. PY - 2012 DA - 2012// TI - Cancer prevention for global health: a report from the ASPO International Cancer Prevention Interest Group JO - Cancer Epidemiol. Biomarkers Prev. VL - 21 UR - https://doi.org/10.1158/1055-9965.EPI-12-0848 DO - 10.1158/1055-9965.EPI-12-0848 ID - Braithwaite2012 ER - TY - JOUR AU - Vigneri, P. AU - Frasca, F. AU - Sciacca, L. AU - Pandini, G. AU - Vigneri, R. PY - 2009 DA - 2009// TI - Diabetes and cancer JO - Endocr. Relat. Cancer. VL - 16 UR - https://doi.org/10.1677/ERC-09-0087 DO - 10.1677/ERC-09-0087 ID - Vigneri2009 ER - TY - JOUR AU - Barone, B. B. PY - 2008 DA - 2008// TI - Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis JO - JAMA VL - 300 UR - https://doi.org/10.1001/jama.2008.824 DO - 10.1001/jama.2008.824 ID - Barone2008 ER - TY - JOUR AU - Stattin, P. PY - 2007 DA - 2007// TI - Prospective study of hyperglycemia and cancer risk JO - Diabetes Care VL - 30 UR - https://doi.org/10.2337/dc06-0922 DO - 10.2337/dc06-0922 ID - Stattin2007 ER - TY - JOUR AU - Seshasai, S. R. PY - 2011 DA - 2011// TI - Diabetes mellitus, fasting glucose, and risk of cause-specific death JO - N. Engl. J. Med. VL - 364 UR - https://doi.org/10.1056/NEJMoa1008862 DO - 10.1056/NEJMoa1008862 ID - Seshasai2011 ER - TY - JOUR AU - Brownlee, M. AU - Cerami, A. AU - Vlassara, H. PY - 1988 DA - 1988// TI - Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications JO - N. Engl. J. Med. VL - 318 UR - https://doi.org/10.1056/NEJM198805193182007 DO - 10.1056/NEJM198805193182007 ID - Brownlee1988 ER - TY - JOUR AU - Dyer, D. G. AU - Blackledge, J. A. AU - Thorpe, S. R. AU - Baynes, J. W. PY - 1991 DA - 1991// TI - Formation of pentosidine during nonenzymatic browning of proteins by glucose. Identification of glucose and other carbohydrates as possible precursors of pentosidine in vivo JO - J. Biol. Chem. VL - 266 ID - Dyer1991 ER - TY - JOUR AU - Genuth, S. PY - 2005 DA - 2005// TI - Glycation and carboxymethyllysine levels in skin collagen predict the risk of future 10-year progression of diabetic retinopathy and nephropathy in the diabetes control and complications trial and epidemiology of diabetes interventions and complications participants with type 1 diabetes JO - Diabetes VL - 54 UR - https://doi.org/10.2337/diabetes.54.11.3103 DO - 10.2337/diabetes.54.11.3103 ID - Genuth2005 ER - TY - JOUR AU - Bucala, R. PY - 2014 DA - 2014// TI - Diabetes, aging, and their tissue complications JO - J. Clin. Invest. VL - 124 UR - https://doi.org/10.1172/JCI75224 DO - 10.1172/JCI75224 ID - Bucala2014 ER - TY - JOUR AU - Yamagishi, S. I. AU - Nakamura, N. AU - Matsui, T. PY - 2017 DA - 2017// TI - Glycation and cardiovascular disease in diabetes: A perspective on the concept of metabolic memory JO - J. Diabetes. VL - 9 UR - https://doi.org/10.1111/1753-0407.12475 DO - 10.1111/1753-0407.12475 ID - Yamagishi2017 ER - TY - JOUR AU - Fleming, T. H. AU - Humpert, P. M. AU - Nawroth, P. P. AU - Bierhaus, A. PY - 2011 DA - 2011// TI - Reactive metabolites and AGE/RAGE-mediated cellular dysfunction affect the aging process: a mini-review JO - Gerontology VL - 57 ID - Fleming2011 ER - TY - JOUR AU - Ramasamy, R. AU - Yan, S. F. AU - Schmidt, A. M. PY - 2011 DA - 2011// TI - Receptor for AGE (RAGE): signaling mechanisms in the pathogenesis of diabetes and its complications JO - Ann. NY Acad. Sci. VL - 1243 UR - https://doi.org/10.1111/j.1749-6632.2011.06320.x DO - 10.1111/j.1749-6632.2011.06320.x ID - Ramasamy2011 ER - TY - JOUR AU - Ward, M. S. AU - Fortheringham, A. K. AU - Cooper, M. E. AU - Forbes, J. M. PY - 2013 DA - 2013// TI - Targeting advanced glycation endproducts and mitochondrial dysfunction in cardiovascular disease JO - Curr. Opin. Pharmacol. VL - 13 UR - https://doi.org/10.1016/j.coph.2013.06.009 DO - 10.1016/j.coph.2013.06.009 ID - Ward2013 ER - TY - JOUR AU - Chen, M. AU - Curtis, T. M. AU - Stitt, A. W. PY - 2013 DA - 2013// TI - Advanced glycation end products and diabetic retinopathy JO - Curr. Med. Chem. VL - 20 UR - https://doi.org/10.2174/09298673113209990025 DO - 10.2174/09298673113209990025 ID - Chen2013 ER - TY - JOUR AU - Yamagishi, S. AU - Matsui, T. AU - Fukami, K. PY - 2015 DA - 2015// TI - Role of receptor for advanced glycation end products (RAGE) and its ligands in cancer risk JO - Rejuvenation Res. VL - 18 UR - https://doi.org/10.1089/rej.2014.1625 DO - 10.1089/rej.2014.1625 ID - Yamagishi2015 ER - TY - JOUR AU - Yamamoto, Y. AU - Yamagishi, S. AU - Hsu, C. C. AU - Yamamoto, H. PY - 1996 DA - 1996// TI - Advanced glycation end products: receptor interactions stimulate the growth of human pancreatic cancer cells through the induction of platelet-derived growth factor-B JO - Biochem. Biophys. Res. Commun. VL - 222 UR - https://doi.org/10.1006/bbrc.1996.0807 DO - 10.1006/bbrc.1996.0807 ID - Yamamoto1996 ER - TY - JOUR AU - Abe, R. PY - 2004 DA - 2004// TI - Regulation of human melanoma growth and metastasis by AGE-AGE receptor interactions JO - J. Invest. Dermatol. VL - 122 UR - https://doi.org/10.1046/j.0022-202X.2004.22218.x DO - 10.1046/j.0022-202X.2004.22218.x ID - Abe2004 ER - TY - JOUR AU - Ishibashi, Y. AU - Matsui, T. AU - Takeuchi, M. AU - Yamagishi, S. PY - 2013 DA - 2013// TI - Metformin inhibits advanced glycation end products (AGEs)-induced growth and VEGF expression in MCF-7 breast cancer cells by suppressing AGEs receptor expression via AMP-activated protein kinase JO - Horm. Metab. Res. VL - 45 ID - Ishibashi2013 ER - TY - JOUR AU - Ellington, A. D. AU - Szostak, J. W. PY - 1990 DA - 1990// TI - In vitro selection of RNA molecules that bind specific ligands JO - Nature VL - 346 UR - https://doi.org/10.1038/346818a0 DO - 10.1038/346818a0 ID - Ellington1990 ER - TY - JOUR AU - Sun, H. AU - Zu, Y. PY - 2015 DA - 2015// TI - A highlight of recent advances in aptamer technology and its application JO - Molecules VL - 20 UR - https://doi.org/10.3390/molecules200711959 DO - 10.3390/molecules200711959 ID - Sun2015 ER - TY - JOUR AU - Matsui, T. PY - 2017 DA - 2017// TI - RAGE-aptamer blocks the development and progression of experimental diabetic nephropathy JO - Diabetes VL - 66 UR - https://doi.org/10.2337/db16-1281 DO - 10.2337/db16-1281 ID - Matsui2017 ER - TY - JOUR AU - Yamagishi, S. PY - 2006 DA - 2006// TI - Pigment epithelium-derived factor inhibits advanced glycation end product-induced retinal vascular hyperpermeability by blocking reactive oxygen species-mediated vascular endothelial growth factor expression JO - J. Biol. Chem. VL - 281 UR - https://doi.org/10.1074/jbc.M602110200 DO - 10.1074/jbc.M602110200 ID - Yamagishi2006 ER - TY - JOUR AU - Ojima, A. PY - 2014 DA - 2014// TI - DNA aptamer raised against advanced glycation end products inhibits melanoma growth in nude mice JO - Lab. Invest. VL - 94 UR - https://doi.org/10.1038/labinvest.2014.5 DO - 10.1038/labinvest.2014.5 ID - Ojima2014 ER - TY - JOUR AU - Matsui, T. AU - Nishino, Y. AU - Takeuchi, M. AU - Yamagishi, S. PY - 2011 DA - 2011// TI - Vildagliptin blocks vascular injury in thoracic aorta of diabetic rats by suppressing advanced glycation end product-receptor axis JO - Pharmacol. Res. VL - 63 UR - https://doi.org/10.1016/j.phrs.2011.02.003 DO - 10.1016/j.phrs.2011.02.003 ID - Matsui2011 ER - TY - JOUR AU - Matsui, T. AU - Oda, E. AU - Higashimoto, Y. AU - Yamagishi, S. PY - 2015 DA - 2015// TI - Glyceraldehyde-derived pyridinium (GLAP) evokes oxidative stress and inflammatory and thrombogenic reactions in endothelial cells via the interaction with RAGE JO - Cardiovasc. Diabetol. VL - 14 UR - https://doi.org/10.1186/s12933-014-0162-3 DO - 10.1186/s12933-014-0162-3 ID - Matsui2015 ER - TY - JOUR AU - Ishibashi, Y. AU - Matsui, T. AU - Yamagishi, S. PY - 2016 DA - 2016// TI - Tofogliflozin, a highly selective inhibitor of SGLT2, blocks proinflammatory and proapoptotic effects of glucose overload on proximal tubular cells partly by suppressing oxidative stress generation JO - Horm. Metab. Res. VL - 48 ID - Ishibashi2016 ER - TY - JOUR AU - Higashimoto, Y. PY - 2007 DA - 2007// TI - In vitro selection of DNA aptamers that block toxic effects of AGE on cultured retinal pericytes JO - Microvasc. Res. VL - 74 UR - https://doi.org/10.1016/j.mvr.2007.04.001 DO - 10.1016/j.mvr.2007.04.001 ID - Higashimoto2007 ER - TY - JOUR AU - Ishibashi, Y. AU - Matsui, T. AU - Ueda, S. AU - Fukami, K. AU - Yamagishi, S. PY - 2014 DA - 2014// TI - Advanced glycation end products potentiate citrated plasma-evoked oxidative and inflammatory reactions in endothelial cells by up-regulating protease-activated receptor-1 expression JO - Cardiovasc. Diabetol. VL - 13 UR - https://doi.org/10.1186/1475-2840-13-60 DO - 10.1186/1475-2840-13-60 ID - Ishibashi2014 ER - TY - JOUR AU - Nakamura, K. PY - 2007 DA - 2007// TI - Pigment epithelium-derived factor inhibits neointimal hyperplasia after vascular injury by blocking NADPH oxidase-mediated reactive oxygen species generation JO - Am. J. Pathol. VL - 170 UR - https://doi.org/10.2353/ajpath.2007.060838 DO - 10.2353/ajpath.2007.060838 ID - Nakamura2007 ER - TY - JOUR AU - Cassarino, D. S. AU - Cabral, E. S. AU - Kartha, R. V. AU - Swetter, S. M. PY - 2008 DA - 2008// TI - Primary dermal melanoma: distinct immunohistochemical findings and clinical outcome compared with nodular and metastatic melanoma JO - Arch. Dermatol. VL - 144 UR - https://doi.org/10.1001/archdermatol.2007.16 DO - 10.1001/archdermatol.2007.16 ID - Cassarino2008 ER - TY - JOUR AU - Gammon, B. AU - Ali, L. AU - Guitart, J. AU - Gerami, P. PY - 2012 DA - 2012// TI - Homogeneous staining regions for cyclin D1, a marker of poor prognosis in malignant melanoma JO - Am. J. Dermatopathol. VL - 34 UR - https://doi.org/10.1097/DAD.0b013e31823894f8 DO - 10.1097/DAD.0b013e31823894f8 ID - Gammon2012 ER - TY - JOUR AU - Abe, R. AU - Yamagishi, S. PY - 2008 DA - 2008// TI - AGE-RAGE system and carcinogenesis JO - Curr. Pharm. Des. VL - 14 UR - https://doi.org/10.2174/138161208784139765 DO - 10.2174/138161208784139765 ID - Abe2008 ER - TY - JOUR AU - Yamagishi, S. PY - 2004 DA - 2004// TI - Minodronate, a newly developed nitrogen-containing bisphosphonate, suppresses melanoma growth and improves survival in nude mice by blocking vascular endothelial growth factor signaling JO - Am. J. Pathol. VL - 165 UR - https://doi.org/10.1016/S0002-9440(10)63239-7 DO - 10.1016/S0002-9440(10)63239-7 ID - Yamagishi2004 ER - TY - JOUR AU - Senger, D. R. PY - 1993 DA - 1993// TI - Vascular permeability factor in tumor biology JO - Cancer Metastasis Rev. VL - 12 UR - https://doi.org/10.1007/BF00665960 DO - 10.1007/BF00665960 ID - Senger1993 ER - TY - JOUR AU - Torisu, H. PY - 2000 DA - 2000// TI - Macrophage infiltration correlates with tumor stage and angiogenesis in human malignant melanoma: possible involvement of TNFalpha and IL-1alpha JO - Int. J. Cancer. VL - 85 UR - https://doi.org/10.1002/(SICI)1097-0215(20000115)85:2%3C182::AID-IJC6%3E3.0.CO;2-M DO - 10.1002/(SICI)1097-0215(20000115)85:2%3C182::AID-IJC6%3E3.0.CO;2-M ID - Torisu2000 ER - TY - JOUR AU - Salven, P. AU - Heikkila, P. AU - Joensuu, H. PY - 1997 DA - 1997// TI - Enhanced expression of vascular endothelial growth factor in metastatic melanoma JO - Br. J. Cancer. VL - 76 UR - https://doi.org/10.1038/bjc.1997.486 DO - 10.1038/bjc.1997.486 ID - Salven1997 ER - TY - JOUR AU - Koga, M. PY - 2008 DA - 2008// TI - Mutant MCP-1 therapy inhibits tumor angiogenesis and growth of malignant melanoma in mice JO - Biochem. Biophys. Res. Commun. VL - 365 UR - https://doi.org/10.1016/j.bbrc.2007.10.182 DO - 10.1016/j.bbrc.2007.10.182 ID - Koga2008 ER - TY - JOUR AU - Shi, L. PY - 2010 DA - 2010// TI - Clinicopathological implications of tumour-associated macrophages and vascularization in sinonasal melanoma JO - J. Int. Med. Res. VL - 38 UR - https://doi.org/10.1177/147323001003800409 DO - 10.1177/147323001003800409 ID - Shi2010 ER - TY - JOUR AU - Chen, P. PY - 2011 DA - 2011// TI - Tumor-associated macrophages promote angiogenesis and melanoma growth via adrenomedullin in a paracrine and autocrine manner JO - Clin. Cancer Res. VL - 17 UR - https://doi.org/10.1158/1078-0432.CCR-11-1354 DO - 10.1158/1078-0432.CCR-11-1354 ID - Chen2011 ER - TY - JOUR AU - Yamagishi, S. PY - 1997 DA - 1997// TI - Advanced glycation end products-driven angiogenesis in vitro. Induction of the growth and tube formation of human microvascular endothelial cells through autocrine vascular endothelial growth factor JO - J. Biol. Chem. VL - 272 UR - https://doi.org/10.1074/jbc.272.13.8723 DO - 10.1074/jbc.272.13.8723 ID - Yamagishi1997 ER - TY - JOUR AU - Matsui, T. AU - Nakamura, N. AU - Ojima, A. AU - Nishino, Y. AU - Yamagishi, S. I. PY - 2016 DA - 2016// TI - Sulforaphane reduces advanced glycation end products (AGEs)-induced inflammation in endothelial cells and rat aorta JO - Nutr. Metab. Cardiovasc. Dis. VL - 26 UR - https://doi.org/10.1016/j.numecd.2016.04.008 DO - 10.1016/j.numecd.2016.04.008 ID - Matsui2016 ER - TY - JOUR AU - Chang, J. S. PY - 2008 DA - 2008// TI - Oxygen deprivation triggers upregulation of early growth response-1 by the receptor for advanced glycation end products JO - Circ. Res. VL - 102 UR - https://doi.org/10.1161/CIRCRESAHA.107.165308 DO - 10.1161/CIRCRESAHA.107.165308 ID - Chang2008 ER - TY - JOUR AU - Kaida, Y. PY - 2013 DA - 2013// TI - DNA aptamer raised against AGEs blocks the progression of experimental diabetic nephropathy JO - Diabetes VL - 62 UR - https://doi.org/10.2337/db12-1608 DO - 10.2337/db12-1608 ID - Kaida2013 ER - TY - JOUR AU - Soro-Paavonen, A. PY - 2008 DA - 2008// TI - Receptor for advanced glycation end products (RAGE) deficiency attenuates the development of atherosclerosis in diabetes JO - Diabetes VL - 57 UR - https://doi.org/10.2337/db07-1808 DO - 10.2337/db07-1808 ID - Soro-Paavonen2008 ER - TY - JOUR AU - Yang, H. AU - Wang, H. AU - Chavan, S. S. AU - Andersson, U. PY - 2015 DA - 2015// TI - High Mobility Group Box Protein 1 (HMGB1): The Prototypical Endogenous Danger Molecule JO - Mol. Med. VL - 21 UR - https://doi.org/10.2119/molmed.2015.00087 DO - 10.2119/molmed.2015.00087 ID - Yang2015 ER -